TrialThe British journal of surgery2024

Disease extent according to baseline [18F]fluorodeoxyglucose PET/CT and molecular subtype: prediction of axillary treatment response after neoadjuvant systemic therapy for breast cancer.

Florien J G van Amstel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.